These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 19875666

  • 1. Pharmacokinetics of bevacizumab and its effect on vascular endothelial growth factor after intravitreal injection of bevacizumab in macaque eyes.
    Miyake T, Sawada O, Kakinoki M, Sawada T, Kawamura H, Ogasawara K, Ohji M.
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1606-8. PubMed ID: 19875666
    [Abstract] [Full Text] [Related]

  • 2. Effect of vitrectomy on aqueous VEGF concentration and pharmacokinetics of bevacizumab in macaque monkeys.
    Kakinoki M, Sawada O, Sawada T, Saishin Y, Kawamura H, Ohji M.
    Invest Ophthalmol Vis Sci; 2012 Aug 24; 53(9):5877-80. PubMed ID: 22836776
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of intravitreal bevacizumab (Avastin).
    Bakri SJ, Snyder MR, Reid JM, Pulido JS, Singh RJ.
    Ophthalmology; 2007 May 24; 114(5):855-9. PubMed ID: 17467524
    [Abstract] [Full Text] [Related]

  • 4. Effects of intravitreally injected bevacizumab on vascular endothelial growth factor in fellow eyes.
    Matsuyama K, Ogata N, Matsuoka M, Wada M, Nishimura T, Takahashi K.
    J Ocul Pharmacol Ther; 2011 Aug 24; 27(4):379-83. PubMed ID: 21810018
    [Abstract] [Full Text] [Related]

  • 5. Concentration of vascular endothelial growth factor in aqueous humor of eyes with advanced retinopathy of prematurity before and after intravitreal injection of bevacizumab.
    Nonobe NI, Kachi S, Kondo M, Takai Y, Takemoto K, Nakayama A, Hayakawa M, Terasaki H.
    Retina; 2009 May 24; 29(5):579-85. PubMed ID: 19430279
    [Abstract] [Full Text] [Related]

  • 6. Concentrations of unbound bevacizumab in the aqueous of untreated fellow eyes after a single intravitreal injection in humans.
    Meyer CH, Krohne TU, Holz FG.
    Acta Ophthalmol; 2012 Feb 24; 90(1):68-70. PubMed ID: 20163369
    [Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factor in aqueous humor before and after intravitreal injection of bevacizumab in eyes with diabetic retinopathy.
    Sawada O, Kawamura H, Kakinoki M, Sawada T, Ohji M.
    Arch Ophthalmol; 2007 Oct 24; 125(10):1363-6. PubMed ID: 17923544
    [Abstract] [Full Text] [Related]

  • 8. Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans.
    Krohne TU, Eter N, Holz FG, Meyer CH.
    Am J Ophthalmol; 2008 Oct 24; 146(4):508-12. PubMed ID: 18635152
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of intravitreal ranibizumab (Lucentis).
    Bakri SJ, Snyder MR, Reid JM, Pulido JS, Ezzat MK, Singh RJ.
    Ophthalmology; 2007 Dec 24; 114(12):2179-82. PubMed ID: 18054637
    [Abstract] [Full Text] [Related]

  • 10. Effect of intravitreal bevacizumab injection on aqueous humor cytokine levels in clinically significant macular edema.
    Roh MI, Kim HS, Song JH, Lim JB, Kwon OW.
    Ophthalmology; 2009 Jan 24; 116(1):80-6. PubMed ID: 19118699
    [Abstract] [Full Text] [Related]

  • 11. Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization.
    Zhu Q, Ziemssen F, Henke-Fahle S, Tatar O, Szurman P, Aisenbrey S, Schneiderhan-Marra N, Xu X, Tübingen Bevacizumab Study Group, Grisanti S.
    Ophthalmology; 2008 Oct 24; 115(10):1750-5, 1755.e1. PubMed ID: 18708261
    [Abstract] [Full Text] [Related]

  • 12. Changes in aqueous vascular endothelial growth factor and pigment epithelial-derived factor levels following intravitreal bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia.
    Chan WM, Lai TY, Chan KP, Li H, Liu DT, Lam DS, Pang CP.
    Retina; 2008 Oct 24; 28(9):1308-13. PubMed ID: 18728623
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits.
    Nomoto H, Shiraga F, Kuno N, Kimura E, Fujii S, Shinomiya K, Nugent AK, Hirooka K, Baba T.
    Invest Ophthalmol Vis Sci; 2009 Oct 24; 50(10):4807-13. PubMed ID: 19324856
    [Abstract] [Full Text] [Related]

  • 14. Ranibizumab and Aflibercept: Intraocular Pharmacokinetics and Their Effects on Aqueous VEGF Level in Vitrectomized and Nonvitrectomized Macaque Eyes.
    Niwa Y, Kakinoki M, Sawada T, Wang X, Ohji M.
    Invest Ophthalmol Vis Sci; 2015 Oct 24; 56(11):6501-5. PubMed ID: 26447985
    [Abstract] [Full Text] [Related]

  • 15. Levels of erythropoietin and vascular endothelial growth factor in surgery-required advanced neovascular glaucoma eyes before and after intravitreal injection of bevacizumab.
    Zhou M, Chen S, Wang W, Huang W, Cheng B, Ding X, Zhang X.
    Invest Ophthalmol Vis Sci; 2013 Jun 04; 54(6):3874-9. PubMed ID: 23674760
    [Abstract] [Full Text] [Related]

  • 16. Intraocular pharmacokinetics after a single intravitreal injection of 1.5 mg versus 3.0 mg of bevacizumab in humans.
    Meyer CH, Krohne TU, Holz FG.
    Retina; 2011 Oct 04; 31(9):1877-84. PubMed ID: 21738089
    [Abstract] [Full Text] [Related]

  • 17. Vascular endothelial growth factor in fellow eyes of eyes injected with intravitreal bevacizumab.
    Sawada O, Kawamura H, Kakinoki M, Ohji M.
    Graefes Arch Clin Exp Ophthalmol; 2008 Oct 04; 246(10):1379-81. PubMed ID: 18581130
    [Abstract] [Full Text] [Related]

  • 18. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
    Arimura N, Otsuka H, Yamakiri K, Sonoda Y, Nakao S, Noda Y, Hashiguchi T, Maruyama I, Sakamoto T.
    Ophthalmology; 2009 May 04; 116(5):921-6. PubMed ID: 19410951
    [Abstract] [Full Text] [Related]

  • 19. Preparation, characterization, and in vivo evaluation of nanoliposomes-encapsulated bevacizumab (avastin) for intravitreal administration.
    Abrishami M, Zarei-Ghanavati S, Soroush D, Rouhbakhsh M, Jaafari MR, Malaekeh-Nikouei B.
    Retina; 2009 May 04; 29(5):699-703. PubMed ID: 19430280
    [Abstract] [Full Text] [Related]

  • 20. Aqueous humor concentration of bevacizumab after subconjunctival injection in rabbit.
    Kim MJ, Han ES, Kim J, Kim TW.
    J Ocul Pharmacol Ther; 2010 Feb 04; 26(1):49-53. PubMed ID: 20148650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.